PD cell model experiments confirmed that pathological αS (e.g., 3K mutants or E46K) impairs vesicle trafficking and forms inclusion bodies by accelerating APT1-mediated depalmitoylation of microtubule-associated-protein-6 (MAP6) and impairing its ability to bind to vesicles. The gene discussed is MAP6; the disease is Parkinson disease.